IP Verse

Improved Process For The Preparation Of Immunoglobulin G (Igg) - EP3071596

The patent EP3071596 was granted to BIO Products Laboratory on Sep 21, 2022. The application was originally filed on Jul 24, 2015 under application number EP15744309A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3071596

BIO PRODUCTS LABORATORY
Application Number
EP15744309A
Filing Date
Jul 24, 2015
Status
Patent Maintained As Amended
Aug 19, 2022
Grant Date
Sep 21, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TAKEDA PHARMACEUTICALSMay 29, 2019HOFFMANN EITLEADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTEP0078331
INTERNATIONAL-SEARCH-REPORTEP0764658
INTERNATIONAL-SEARCH-REPORTUS4246085
INTERNATIONAL-SEARCH-REPORTWO2008068455
INTERNATIONAL-SEARCH-REPORTWO2010132686
INTERNATIONAL-SEARCH-REPORTWO2012080422
OPPOSITIONEP0764658
OPPOSITIONUS2014141021
OPPOSITIONUS8466265
OPPOSITIONUS9718856
OPPOSITIONWO2013126904
OPPOSITIONWO2013132053
OPPOSITIONWO9732654

Non-Patent Literature (NPL) Citations (16) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- KORNEYEVA M ET AL, "ENVELOPED VIRUS INACTIVATION BY CAPRYLATE: A ROBUST ALTERNATIVE TO SOLVENT-DETERGENT TREATMENT IN PLASMA DERIVED INTERMEDIATES", BIOLOGICALS, ACADEMIC PRESS LTD., LONDON, GB, (20020601), vol. 30, no. 2, doi:10.1006/BIOL.2002.0334, ISSN 1045-1056, pages 153 - 162, XP001197368 [X] 1-6,11-19 * the whole document * [Y] 7-10,20-24
INTERNATIONAL-SEARCH-REPORT- ZHUO LIU ET AL, "Purification of human immunoglobulins A, G and M from Cohn fraction II/III by small peptide affinity chromatography", JOURNAL OF CHROMATOGRAPHY A, (20121101), vol. 1262, doi:10.1016/j.chroma.2012.09.026, ISSN 0021-9673, pages 169 - 179, XP055158016 [X] 1-6,11-19 * the whole document * [Y] 7-10,20-24
INTERNATIONAL-SEARCH-REPORT- MARTIN TURF D ED - AHMED A RAZZAQUE, "IGIV: Contents, properties, and methods of industrial production-evolving closer to a more physiologic pro", INTERNATIONAL IMMUNOPHARMACOLOGY, (2006), vol. 6, no. 4, doi:10.1016/J.INTIMP.2005.11.005, ISSN 1567-5769, pages 517 - 522, XP029128397 [X] 1-6,11-19 * the whole document * [Y] 7-10,20-24
INTERNATIONAL-SEARCH-REPORT- TANAKA K ET AL, "High quality human immunoglobulin G purified from Cohn fractions by liquid chromatography", BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, RIBEIRAO PRETO, BR, (20000101), vol. 33, no. 1, doi:10.1590/S0100-879X2000000100004, ISSN 0100-879X, pages 27 - 30, XP002967265 [X] 1-6,11-19 * the whole document * [Y] 7-10,20-24
OPPOSITION- 2nd Declaration Dr. W. Teschner-
OPPOSITION- CV W. Teschner-
OPPOSITION- Declaration Dr. W. Teschner-
OPPOSITION- "Human Normal Immunoglobulin for intravenous administration", European Pharmacopoeia fifth edition, Strasbourg Cedex, France, vol. 2, pages 1 - 7, ISBN 92-871-5281-0-
OPPOSITION- "Human Normal Immunoglobulin for intravenous administration", European Pharmacopoeia fifth edition, Strasbourg Cedex, France, vol. 2, pages 1 - 7, ISBN 92-871-5281-0, XP055608071-
OPPOSITION- J. Matteson et al, Filtration Principals and Practices, 2nd Edition-
OPPOSITION- KISTLER et al., "Large scale production of human plasma fractions", Vox Sang, (19620000), vol. 7, pages 414 - 424-
OPPOSITION- KISTLER et al., "Large scale production of human plasma fractions", Vox Sang, (19620000), vol. 7, pages 414 - 424, XP001048178-
OPPOSITION- Kistler P., Et Al., "Ethanol precipation", Methods of Plasma Protein Fractionation, London New York Toronto Sydney San Francisco, (19800000), pages 3 - 15-
OPPOSITION- Kistler P., Et Al., "Ethanol precipation", Methods of Plasma Protein Fractionation, London New York Toronto Sydney San Francisco, (19800000), pages 3 - 15, XP055608056-
OPPOSITION- ONCLEY et al., "Subfractions of human plasma", Am Chem Soc, (19490200), vol. 71, pages 541 - 550-
OPPOSITION- ONCLEY et al., "Subfractions of human plasma", Am Chem Soc, (19490200), vol. 71, pages 541 - 550, XP055608058-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents